Principal Software Engineer - Computational Chemistry / Molecular Dyna…
Genesis Therapeutics- Full Time
- Junior (1 to 2 years)
Candidates should possess a Ph.D. in a relevant scientific discipline, such as computational chemistry, bioinformatics, or a related field, and demonstrate a strong background in cheminformatics, molecular modeling, and fragment-based drug discovery. Experience with structure-based drug design, molecular dynamics simulations, and machine learning techniques is highly desirable.
The Computational Scientist will utilize state-of-the-art software to grow, link, and merge fragment hits into novel chemical designs, collaborating with informaticians to develop improved methods for this process. They will triage and analyze data from various experiments, including SPR, NMR, crystallography, and cryo-EM, to generate actionable hypotheses, and contribute to the overall transformation of fragment-based lead discovery through the integration of computational tools and techniques.
Develops and delivers prescription medicines globally
Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.